Cargando…
A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer
Targeted cancer therapies, while often effective, have limited utility due to preexisting primary or acquired secondary resistance. Consequently, agents are sometimes used in combination to simultaneously affect multiple targets. MicroRNA mimics are excellent therapeutic candidates because of their...
Autores principales: | Kasinski, Andrea L., Kelnar, Kevin, Stahlhut, Carlos, Orellana, Esteban, Zhao, Jane, Shimer, Eliot, Dysart, Sarah, Chen, Xiaowei, Bader, Andreas G., Slack, Frank J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4345154/ https://www.ncbi.nlm.nih.gov/pubmed/25174400 http://dx.doi.org/10.1038/onc.2014.282 |
Ejemplares similares
-
The Role of MicroRNAs in Cancer
por: Stahlhut Espinosa, Carlos E., et al.
Publicado: (2007) -
MicroRNAs in Cancer: A Historical Perspective on the Path from Discovery to Therapy
por: Orellana, Esteban A., et al.
Publicado: (2015) -
MicroRNAs and the cancer phenotype: profiling, signatures and clinical implications
por: Stahlhut, Carlos, et al.
Publicado: (2013) -
Regression of murine lung tumors by the let-7 microRNA
por: Trang, Phong, et al.
Publicado: (2009) -
MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic
por: Li, Wen (Jess), et al.
Publicado: (2021)